Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 28;44(1):115192.
doi: 10.1016/j.celrep.2024.115192. Epub 2025 Jan 11.

A conserved switch to less catalytically active Polycomb repressive complexes in non-dividing cells

Affiliations

A conserved switch to less catalytically active Polycomb repressive complexes in non-dividing cells

Rachel McCole et al. Cell Rep. .

Abstract

Polycomb repressive complex 2 (PRC2), composed of the core subunits EED, SUZ12, and either EZH1 or EZH2, is critical for maintaining cellular identity in multicellular organisms. PRC2 deposits H3K27me3, which is thought to recruit the canonical form of PRC1 (cPRC1) to promote gene repression. Here, we show that EZH1-PRC2 and cPRC1 are the primary Polycomb complexes on target genes in non-dividing, quiescent cells. Furthermore, these cells are resistant to PRC2 inhibitors. While PROTAC-mediated degradation of EZH1-PRC2 in quiescent cells does not reduce H3K27me3, it partially displaces cPRC1. Our results reveal an evolutionarily conserved switch to less catalytically active Polycomb complexes in non-dividing cells and raise concerns about using PRC2 inhibitors in cancers with significant populations of non-dividing cells.

Keywords: CBX7; CP: Molecular biology; EED; EZH1; EZH2; H3K27me3; PRC1; PRC2; PROTAC; Polycomb; cellular quiescence.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Similar articles

Cited by

  • A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.
    Lagan E, Gannon D, Silva AJ, Bibawi P, Doherty AM, Nimmo D, McCole R, Monger C, Genesi GL, Vanderlinden A, Innes JA, Jones CLE, Yang L, Chen B, van Mierlo G, Jansen PWTC, Pednekar C, Von Kriegsheim A, Wynne K, Sánchez-Rivera FJ, Soto-Feliciano YM, Carcaboso AM, Vermeulen M, Oliviero G, Chen CW, Phillips RE, Bracken AP, Brien GL. Lagan E, et al. Mol Cell. 2025 Jun 5;85(11):2110-2127.e7. doi: 10.1016/j.molcel.2025.04.026. Epub 2025 May 21. Mol Cell. 2025. PMID: 40403727

References

    1. Schuettengruber B, Bourbon HM, Di Croce L, and Cavalli G (2017). Genome Regulation by Polycomb and Trithorax: 70 Years and Counting. Cell 171, 34–57. 10.1016/j.cell.2017.08.002. - DOI - PubMed
    1. Deevy O, and Bracken AP (2019). PRC2 functions in development and congenital disorders. Development 146, dev181354. 10.1242/dev.181354. - DOI - PMC - PubMed
    1. Bracken AP, and Helin K (2009). Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 9, 773–784. 10.1038/nrc2736. - DOI - PubMed
    1. Blackledge NP, and Klose RJ (2021). The molecular principles of gene regulation by Polycomb repressive complexes. Nat. Rev. Mol. Cell Biol 22, 815–833. 10.1038/s41580-021-00398-y. - DOI - PMC - PubMed
    1. Bracken AP, Brien GL, and Verrijzer CP (2019). Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer. Genes Dev 33, 936–959. 10.1101/gad.326066.119. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Associated data

LinkOut - more resources